Stage II Breast Cancer Terminated Phase 1 Trials for Rosuvastatin (DB01098)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01051401Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast CancerTreatment